February 14, 2017: FemPulse Enrolls First Clinical Study Subject
The Company is pleased to announce the first enrollment in its clinical evaluation to assess fit, comfort, patient placement and safety of the FemPulse therapy, as well as the potential for improvement in symptoms associated with OAB. The subject, a 69 year old female, was afflicted with urgency and urinary urge incontinence.
February 13, 2017: FemPulse Establishes Highly-Experienced Board of Directors
FemPulse LLC announces the formation of a formal board of directors (BoD) to help guide the strategic direction for the fast-moving organization. Members of the BoD includes the co-founders, Alexandra Haessler, MD and Peter Fredericks, MBA/PhD and Donald Deyo, Jeff Korn, Darrin Uecker and Flip Gianos. Don and Jeff serve as CEO and Corporate Counsel […]
